Form 8.3 - WILLIS TOWERS WATSON PLC

LONDON--()-- 

FORM 8.3

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1. KEY INFORMATION

Name of person dealing (Note 1)

Barclays PLC.

Company dealt in

WILLIS TOWERS WATSON PLC

Class of relevant security to which the dealings being disclosed relate (Note 2)

ORD

Date of dealing

23 March 2021

2. INTERESTS AND SHORT POSITIONS

(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

Class of relevant security: ORD
Long Short
Number (%) Number (%)

(1)

Relevant securities

1,790,295

1.39%

189,753

0.15%

 

(2)

Derivatives (other than options):

102,935

0.08%

7,066

0.01%

 

(3)

Options and agreements to
purchase/sell:

6,100

0.00%

6,100

0.00%

 
TOTAL:

1,899,330

1.47%

202,919

0.16%

 

(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security:

Long

Short

 

Number

 

(%)

Number

 

(%)

(1) Relevant securities

 

 

 

(2) Derivatives (other than options)

 

 

 

(3) Options and agreements to purchase/sell

 

 

Total

 

 

 

Ap20

3. DEALINGS (Note 4)

(a) Purchases and sales

Purchase/sale Number of relevant securities Price per unit
Purchase

1

221.5000 USD
Purchase

1

222.5100 USD
Purchase

19

221.8800 USD
Purchase

33

222.2400 USD
Purchase

100

223.0400 USD
Purchase

100

223.1300 USD
Purchase

100

222.2300 USD
Purchase

200

222.2475 USD
Purchase

246

221.8085 USD
Purchase

300

221.1418 USD
Purchase

392

221.4400 USD
Purchase

400

221.5075 USD
Purchase

478

222.3896 USD
Purchase

1,855

221.4876 USD
Purchase

2,066

221.7052 USD
Purchase

2,600

221.9823 USD
Purchase

6,687

222.0402 USD
Purchase

7,378

222.0485 USD
Purchase

9,042

221.9501 USD
Purchase

9,323

221.4884 USD
Purchase

12,078

221.4900 USD
Purchase

20,883

221.8603 USD
Purchase

22,091

221.7520 USD
Sale

4

221.8162 USD
Sale

19

221.8800 USD
Sale

23

222.0000 USD
Sale

100

220.7600 USD
Sale

100

222.3900 USD
Sale

100

222.4100 USD
Sale

109

221.7002 USD
Sale

176

221.9900 USD
Sale

200

221.5550 USD
Sale

200

222.2475 USD
Sale

200

222.1000 USD
Sale

201

222.0966 USD
Sale

203

221.8750 USD
Sale

246

221.8085 USD
Sale

300

222.0400 USD
Sale

300

221.9016 USD
Sale

300

222.0383 USD
Sale

311

221.8509 USD
Sale

400

221.8418 USD
Sale

467

221.9105 USD
Sale

496

222.0079 USD
Sale

500

222.3220 USD
Sale

500

221.6670 USD
Sale

597

222.0792 USD
Sale

828

221.9800 USD
Sale

869

221.4512 USD
Sale

900

222.0972 USD
Sale

1,747

221.8118 USD
Sale

1,854

221.4875 USD
Sale

2,100

221.9457 USD
Sale

2,238

221.6645 USD
Sale

6,777

222.0593 USD
Sale

6,860

221.9788 USD
Sale

7,563

222.0558 USD
Sale

8,993

222.0725 USD
Sale

10,821

222.0292 USD
Sale

11,603

221.5220 USD
Sale

26,807

221.4900 USD

(b) Derivatives transactions (other than options transactions)

Product name,

e.g. CFD

Nature of transaction

(Note 6)

Number of relevant securities

(Note 7)

Price per unit

(Note 5)

 

 

 

 

(c) Options transactions in respect of existing relevant securities

(i) Writing, selling, purchasing or varying

Product name,

e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 7)

Exercise price

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unit (Note 5)

 

 

 

 

 

 

 

(ii) Exercising

Product name,

e.g. call option

Number of securities

Exercise price per unit (Note 5)

 

 

 

(d) Other dealings (including transactions in respect of new securities) (Note 4)

Nature of transaction

(Note 8)

Details

Price per unit

(if applicable) (Note 5)

 

 

 

 

Ap21

2. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

None

Is a Supplemental Form 8 attached? (Note 9) YES

Date of disclosure

24 March 2021

Contact name

Large Holdings Regulatory Operations

Telephone number

020 3134 7213

If a connected EFM, name of offeree/offeror with which connected

 

If a connected EFM, state nature of connection (Note 10)

 

Ap23

SUPPLEMENTAL FORM 8

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DETAILS OF OPEN POSITIONS

(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as appropriate)

OPEN POSITIONS (Note 1)

Product name Written or Number of Exercise Type Expiry
purchased relevant securities price date
to which the option
or derivative
relates
Put Options Purchased

-100

220.0000

American Jul 16, 2021
Call Options Purchased

100

240.0000

American Jul 16, 2021
Call Options Purchased

6,000

220.0000

American Jul 16, 2021
Put Options Purchased

-6,000

200.0000

American Jul 16, 2021

Notes

1. Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell must also be given on this form.

2. For all prices and other monetary amounts, the currency must be stated.

For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.

Category Code: RET
Sequence Number: 733689
Time of Receipt (offset from UTC): 20210324T115731+0000

Contacts

BARCLAYS PLC

Contacts

BARCLAYS PLC